These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23707983)

  • 1. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of subcutaneous tumors in nude mice mediated by low-frequency ultrasound and microbubbles.
    Shen ZY; Shen E; Diao XH; Bai WK; Zeng MX; Luan YY; Nan SL; Lin YD; Wei C; Chen L; Sun D; Hu B
    Oncol Lett; 2014 May; 7(5):1385-1390. PubMed ID: 24765142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of low-frequency ultrasound and microbubbles on rabbit hepatic tumors.
    Shen ZY; Xia GL; Wu MF; Shi MX; Qiang FL; Shen E; Hu B
    Exp Biol Med (Maywood); 2014 Jun; 239(6):747-57. PubMed ID: 24719377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-frequency low-intensity ultrasound with microbubbles on prostate cancer hypoxia.
    Hou R; Xu Y; Lu Q; Zhang Y; Hu B
    Tumour Biol; 2017 Oct; 39(10):1010428317719275. PubMed ID: 28974155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 as a biomarker to predict therapeutic effect of low-frequency ultrasound combined with SonoVue on prostate cancer in nude mice model.
    Xu W; Nan S; Bai W; Shen E; Hu B
    Cancer Biomark; 2014; 14(4):279-86. PubMed ID: 24934371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of ultrasound-targeted vascular endothelial growth factor receptor-2 in non-invasive monitoring of anti-angiogenic response in nude mice with subcutaneous xenograft model].
    Wang L; Lu YH; Wang TY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):856-860. PubMed ID: 33113627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound].
    Hu GQ; Yang L; Xiao YB; Xie JJ; Wu JF; Cai JJ; Liu J; Liao WJ; Bin JP
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):655-8. PubMed ID: 21122377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
    Weller GE; Wong MK; Modzelewski RA; Lu E; Klibanov AL; Wagner WR; Villanueva FS
    Cancer Res; 2005 Jan; 65(2):533-9. PubMed ID: 15695396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular characterization of ultrasound-stimulated microbubble radiation enhancement in a prostate cancer xenograft model.
    Al-Mahrouki AA; Iradji S; Tran WT; Czarnota GJ
    Dis Model Mech; 2014 Mar; 7(3):363-72. PubMed ID: 24487407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-frequency and low-intensity ultrasound-mediated microvessel disruption enhance the effects of radiofrequency ablation on prostate cancer xenografts in nude mice.
    Yang Y; Bai W; Chen Y; Zhang W; Wang M; Hu B
    Mol Med Rep; 2015 Nov; 12(5):7517-25. PubMed ID: 26458324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
    Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency low energy ultrasound combined with microbubbles induces distinct apoptosis of A7r5 cells.
    Zhang B; Zhou H; Cheng Q; Lei L; Hu B
    Mol Med Rep; 2014 Dec; 10(6):3282-8. PubMed ID: 25324182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
    Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
    Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
    Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
    J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in vivo experimental study.
    Nie F; Xu HX; Lu MD; Wang Y; Tang Q
    J Drug Target; 2008 Jun; 16(5):389-95. PubMed ID: 18569283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.
    Klotz LV; Clevert DA; Scheckinger S; Strieth S; Eichhorn ME
    Anticancer Res; 2015 May; 35(5):2571-6. PubMed ID: 25964532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
    Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
    J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.